Seegene Launches New Test for Multidrug-Resistant Organisms in Europe
The assay is CE marked under the European Union In Vitro Diagnostic Regulation and identifies resistance genes to help prevent hospital-acquired infections.
The assay is CE marked under the European Union In Vitro Diagnostic Regulation and identifies resistance genes to help prevent hospital-acquired infections.
The diagnostic tool identifies a specific biological cause of autism with more than 97% predictive accuracy.
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
Beckman Coulter Diagnostics' DxC 500i Clinical Analyzer has received FDA 510(k) clearance, improving networking capabilities.
The Guardant Hereditary Cancer test is a blood-based genetic screening tool that identifies inherited cancer risk variants.
Having high-quality assays, molecular controls, and automated workflow solutions are critical in...